World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
26023
World Ranking
13715
National Ranking
6965

Arlene B. Chapman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Arlene B. Chapman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 346 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Arlene B. Chapman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Arlene B. Chapman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Arlene B. Chapman is affiliated with the University of Chicago in the United States. Their research primarily spans medicine and biochemistry, genetics, and molecular biology, with a particular focus on nephrology and genetics within those fields.

Their scientific work centers around several subfields including nephrology, genetics, pulmonary and respiratory medicine, molecular biology, and surgery. The main research topics cover genetic and kidney cyst diseases, pharmacogenetics and drug metabolism, dialysis and renal disease management, renal diseases and glomerulopathies, MRI in cancer diagnosis, cell adhesion molecules research, and studies related to blood pressure and hypertension.

Significant publication venues for Arlene B. Chapman include the Journal of the American Society of Nephrology, Kidney Medicine, Kidney360, Metabolites, and the American Journal of Nephrology.

Frequent coauthors collaborating with Chapman have included Rhonda M. Cooper-DeHoff, Bradley A. Warady, Peter Stenvinkel, Glenn M. Chertow, and John G. Gums.

Recent papers authored or coauthored by Chapman include:

  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure (2023, Nature Medicine)
  • Alport Syndrome Classification and Management (2020, Kidney Medicine)
  • Effects of Bardoxolone Methyl in Alport Syndrome (2022, Clinical Journal of the American Society of Nephrology)
  • KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary (2025, Kidney International)
  • Emerging Role of Clinical Genetics in CKD (2022, Kidney Medicine)

Chapman has been recognized as a member of the Association of American Physicians.

Best Publications

  • Tolvaptan in patients with autosomal dominant polycystic kidney disease

    Vicente E. Torres;Arlene B. Chapman;Olivier Devuyst;Olivier Devuyst;Ron T. Gansevoort

  • Volume Progression in Polycystic Kidney Disease

    Jared J. Grantham;Vicente E. Torres;Arlene B. Chapman;Lisa M. Guay-Woodford

  • Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.

    Arlene B. Chapman;William T. Abraham;Stacy Zamudio;Carolyn Coffin

  • Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials

    María V. Irazabal;Laureano J. Rangel;Eric J. Bergstralh;Sara L. Osborn

  • Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

    Vicente E Torres;Arlene B Chapman;Olivier Devuyst;Olivier Devuyst;Ron T Gansevoort

  • Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Arlene B. Chapman;Olivier Devuyst;Kai-Uwe Eckardt;Ron T. Gansevoort

  • The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.

    Arlene B. Chapman;Ann Johnson;Patricia A. Gabow;Robert W. Schrier

  • Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Robert W. Schrier;Robert W. Schrier;Kaleab Z. Abebe;Ronald D. Perrone;Vicente E. Torres

  • Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

    Sandro Rossetti;Mark B. Consugar;Arlene B. Chapman;Vicente E. Torres

  • Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

    Arlene B. Chapman;Lisa M. Guay-Woodford;Jared J. Grantham;Vicente E. Torres

  • Intracranial aneurysms in autosomal dominant polycystic kidney disease.

    Arlene B. Chapman;David Rubinstein;Richard Hughes;John C. Stears

  • Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease

    Arlene B. Chapman;James E. Bost;Vicente E. Torres;Lisa Guay-Woodford

  • Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease

    Binu Porath;Vladimir G. Gainullin;Emilie Cornec-Le Gall;Emilie Cornec-Le Gall;Elizabeth K. Dillinger

  • Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

    Kyongtae T. Bae;Fang Zhu;Arlene B. Chapman;Vicente E. Torres

  • Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.

    Jared J. Grantham;Arlene B. Chapman;Vicente E. Torres

  • Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease: Results of a Seven-Year Prospective Randomized Study

    Robert Schrier;Kimberly McFann;Ann Johnson;Arlene Chapman

  • Renal structure and hypertension in autosomal dominant polycystic kidney disease

    Patricia A. Gabow;Arlene B. Chapman;Ann M. Johnson;Douglas J. Tangel

  • Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

    Vicente E. Torres;Kaleab Z. Abebe;Arlene B. Chapman;Robert W. Schrier

  • The primary glycosylation defect in class E Thy-1-negative mutant mouse lymphoma cells is an inability to synthesize dolichol-P-mannose.

    A. Chapman;K. Fujimoto;Stuart Kornfeld

  • Cyst Number but Not the Rate of Cystic Growth Is Associated with the Mutated Gene in Autosomal Dominant Polycystic Kidney Disease

    Peter C Harris;Kyongtae T Bae;Sandro Rossetti;Vicente E Torres

Frequent Co-Authors

Julie A. Johnson
Julie A. Johnson University of Florida
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Kyongtae T. Bae
Kyongtae T. Bae University of Pittsburgh
Jared J. Grantham
Jared J. Grantham University of Kansas
Kent R. Bailey
Kent R. Bailey Mayo Clinic
Peter C. Harris
Peter C. Harris Mayo Clinic
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen
Olivier Devuyst
Olivier Devuyst University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field offers diverse career pathways beyond the traditional MD, many of which can be pursued through online education. For those interested in mental health, there are psychiatric np programs that prepare graduates to address the growing demand for mental health professionals. These advanced nursing programs combine clinical skills with psychiatric care, opening opportunities for certified psychiatric nurse practitioners.

If you are drawn to the administrative side of healthcare, online healthcare administration programs and masters in healthcare administration cost are crucial to consider. Online programs provide flexibility for working professionals and can lead to leadership roles in hospitals, clinics, and public health organizations. Exploring affordable options helps minimize debt while pursuing advanced education.

For nurses aiming for the highest level of clinical expertise, the cheapest dnp online programs offer a pathway to a Doctor of Nursing Practice — a degree that prepares nurses for evidence-based practice and leadership in healthcare systems.

Best Scientists Citing Arlene B. Chapman

Trending Scientists

Recently Published Articles